Arising Novel Agents in Lung Cancer: Are Bispecifics and ADCs the New Paradigm?

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related death worldwide according to the World Health Organization. Non-small cell lung cancer makes up the majority of cases. Immunotherapy with immune checkpoint inhibitors and targeted therapy with tyrosine kinase inhibitors and other mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, Amanda, Pharaon, Rebecca, Mohanty, Atish, Massarelli, Erminia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296730/
https://www.ncbi.nlm.nih.gov/pubmed/37370772
http://dx.doi.org/10.3390/cancers15123162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296730/
https://www.ncbi.nlm.nih.gov/pubmed/37370772
http://dx.doi.org/10.3390/cancers15123162

Ejemplares similares